Pharmaceuticals

Antifungals Market Trends and Insights: Global Forecast to 2030

February 12, 2026February 12, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the antifungals market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Antifungals Market between 2026 and 2030?

The antifungals market size has demonstrated strong expansion in recent years. It is projected to increase from $29.6 billion in 2025 to $31.98 billion in 2026, registering a compound annual growth rate (CAGR) of 8.1%. The growth observed in the past can be attributed to several factors including an increase in hospital-acquired infections, the widespread adoption of azoles, a growing immunosuppressed population, established antifungal therapies, and the global burden of mycoses.

The antifungals market is anticipated to witness robust expansion in the forthcoming years. It is projected to reach $44.96 billion by 2030, progressing at a compound annual growth rate (CAGR) of 8.9%. This forecasted growth can be ascribed to an increase in systemic fungal infections, growing concerns regarding antifungal resistance, the demand for more secure therapies, the expansion of hospital care facilities, and enhanced diagnosis rates. Significant trends during this period involve the rising occurrence of fungal infections, an escalating need for broad-spectrum antifungals, the proliferation of topical antifungal treatments, augmented application in immunocompromised individuals, and the creation of innovative antifungal drug classes.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2442&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Antifungals Market?

The growth of the antifungals market is anticipated to be driven by the rising occurrence of fungal infections. These infections, which involve fungi growing in or on the body, can impact areas like the skin, nails, lungs, and mucous membranes. The increased prevalence is linked to climate change, which fosters environments where fungi can proliferate and adapt to higher temperatures, thus escalating human exposure and infection risks. Antifungals are vital for treating these conditions by hindering fungal growth and reproduction, achieved through mechanisms such as disrupting their cell walls or membranes, impeding essential enzymatic processes, or interfering with vital component synthesis. This action reduces fungal load, alleviates symptoms, and prevents infection dissemination within the body. As an illustration, the UK Health Security Agency reported in May 2025 that bloodstream infections from yeast rose by 4% in 2024 compared to 2023, with cases increasing from 2,170 to 2,247. Consequently, the growing incidence of fungal infections is a key factor propelling the expansion of the antifungals market.

What Segments Are Included Within The Antifungals Market?

The antifungals market covered in this report is segmented –

1) By Drug Type: Echinocandins, Azoles, Polyenes, Allylamines

2) By Route of Administration: Oral, Parenteral, Topical

3) By End users: Hospitals & Clinics, Dermatology clinics, Other Users

Subsegments:

1) By Echinocandins: Caspofungin, Micafungin, Anidulafungin

2) By Azoles: Fluconazole, Itraconazole, Voriconazole, Posaconazole, Ketoconazole

3) By Polyenes: Amphotericin B, Nystatin

4) By Allylamines: Terbinafine, Naftifine

Which Trends Are Guiding The Evolution Of The Antifungals Market?

Major companies in the antifungals market are focusing on product innovation and new formulations, including long-acting echinocandin therapies, to improve patient adherence, reduce how often doses are needed, and meet unaddressed clinical needs in invasive fungal infections. These newer antifungals provide effective fungal suppression through more convenient administration schedules by extending their half-life and altering their pharmacokinetics. As an example, in March 2023, Cidara Therapeutics, a US-based biotechnology company, alongside Melinta Therapeutics (U.S.), announced that the FDA had approved REZZAYO (rezafungin for injection) for treating candidemia and invasive candidiasis. Rezafungin is a once-weekly echinocandin that showed non-inferior efficacy compared to daily caspofungin in clinical trials (ReSTORE Phase 3), while also having a comparable safety profile. The extended dosing capability of REZZAYO addresses a vital gap in antifungal therapy, enhancing treatment continuity and easing the burden on hospitals in acute-care settings.

Who Are The Prominent Global Companies Shaping The Antifungals Market Landscape?

Major companies operating in the antifungals market are Pfizer Inc., Novartis International AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Sanofi S.A., Kramer Laboratories Inc., GlaxoSmithKline plc, Gilead Sciences Inc., Basilea Pharmaceutica AG, Sigma-Aldrich, Astellas Pharma Inc., Janssen Pharmaceutica NV, Zydus Cadila Healthcare Ltd., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma Co. Ltd., Scynexis Inc., Mayne Pharma Inc., Cosmo Pharmaceuticals NV, Leadiant Biosciences Inc, Glenmark Pharmaceuticals Limited, Cidara Therapeutics, MATINAS BIOPHARMA, Mylan N.V., Perrigo Company plc, Wockhardt Ltd., Lupin Limited, Dr. Reddy’s Laboratories Ltd, Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Mayne Pharma Group Limited, Fresenius Kabi AG, Baxter International Inc., Akorn Operating Company LLC, Amphastar Pharmaceuticals Inc., Mylan Institutional LLC, West-Ward Pharmaceuticals Corp., Gland Pharma Limited, Aurobindo Pharma Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/antifungals-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Antifungals Market?

North America was the largest region in the drugs for antifungals market in 2025. The Middle East is expected to be the fastest-growing region in the antifungals market. The regions covered in the antifungals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Antifungals Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2442&type=smp

Browse Through More Reports Similar to the Global Antifungals Market 2026, By The Business Research Company

Antifungals Market Report 2026

https://www.thebusinessresearchcompany.com/report/antifungals-global-market-report

Fungicides Market Report 2026

https://www.thebusinessresearchcompany.com/report/fungicides-global-market-report

Candidiasis Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/candidiasis-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795